Crop Life Science (NSE:CLSL) ROC %: 6.48% (As of Mar. 2026)


NSE:CLSL Crop Life Science Ltd NSE:CLSL
58 GF Score
Price ₹43.00
GF Value ₹54.88
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Crop Life Science ROC %?

Crop Life Science NSE:CLSL 58 ROC % is 6.48% as of Mar. 2026. GuruFocus rates NSE:CLSL with a GF Score™ of 58/100 and a GF Value™ of ₹54.88 (Modestly Undervalued). The stock has 8 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Crop Life Science's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 6.48%.

As of today (2026-07-01), Crop Life Science's WACC % is 10.58%. Crop Life Science's ROC % is 6.12% (calculated using TTM income statement data). Crop Life Science earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Crop Life Science  (NSE:CLSL) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Crop Life Science's WACC % is 10.58%. Crop Life Science's ROC % is 6.12% (calculated using TTM income statement data). Crop Life Science earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Crop Life Science ROC % Related Terms


Crop Life Science ROC % Historical Data

* Premium members only.

The historical data trend for Crop Life Science's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crop Life Science ROC % Chart

Crop Life Science Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial 6.46 8.54 7.07 6.44 6.28

Crop Life Science Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.70 6.82 5.73 5.59 6.48
NSE:CLSL
58GF Score
Crop Life Science Ltd NSE:CLSL
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crop Life Science ROC % Calculation

Crop Life Science's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=128.355 * ( 1 - 29.65% )/( (1359.564 + 1517.308)/ 2 )
=90.2977425/1438.436
=6.28 %

where

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1817.058 - 448.015 - ( 9.479 - max(0, 927.914 - 1420.985+9.479))
=1359.564

Invested Capital(A: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2079.529 - 526.131 - ( 36.09 - max(0, 1137.926 - 1766.585+36.09))
=1517.308

Crop Life Science's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=142.026 * ( 1 - 30.02% )/( (1547.982 + 1517.308)/ 2 )
=99.3897948/1532.645
=6.48 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2195.265 - 621.498 - ( 25.785 - max(0, 1279.69 - 1867.186+25.785))
=1547.982

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2079.529 - 526.131 - ( 36.09 - max(0, 1137.926 - 1766.585+36.09))
=1517.308

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 6.48% mean?
Crop Life Science (NSE:CLSL) has a ROC % of 6.48% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Crop Life Science and its competitors.
Is Crop Life Science's ROC % too high?
Crop Life Science's current ROC % is 6.48%. The Agriculture industry median ROC % is 5.48. Crop Life Science's value of 6.48% is 18.2% above this industry median. Overall, Crop Life Science has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's ROC % compare to CTVA and CF?
Crop Life Science's ROC % of 6.48% can be compared against companies in the Agriculture industry. The industry median ROC % is 5.48. Crop Life Science's value of 6.48% is 18.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for an Agriculture company?
The median ROC % among Agriculture companies is 5.48, based on 257 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current ROC % of 6.48% is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median ROC % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current ROC % is 6.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹54.88, compared to a current price of ₹43.00 — trading 21.6% below its estimated fair value. The current ROC % is 6.48% and 18.2% above the Agriculture industry median of 5.48. Crop Life Science's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current ROC % is 6.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crop Life Science (NSE:CLSL) Overvalued in 2026?

Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued. The current stock price of ₹43.00 is trading 21.6% below its estimated GF Value™ of ₹54.88. GuruFocus considers Crop Life Science to be Modestly Undervalued.

Key valuation signals for NSE:CLSL:

  • ROC %: 6.48%
  • GF Value™: ₹54.88 vs. price of ₹43.00 (21.6% below fair value)
  • GF Score™: 58/100 with 8 warning signs
  • Industry Position: 18.2% above the Agriculture median

No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Crop Life Science Business Description

Address Old Padra Road, 6th Floor, ABS Tower, Near Chakli Circle, Vadodara, GJ, IND, 390007
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
58GF Score

Get the complete analysis for NSE:CLSL

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.00
Price
₹54.88
GF Value